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Abstract
During development, a coordinated and integrated series of events must be accomplished in order to generate
functional neural circuits. Axons must navigate toward target cells, build synaptic connections, and terminate
outgrowth. The PHR proteins (consisting of mammalian Phr1/MYCBP2, Drosophila Highwire and C. elegans RPM-1)
function in each of these events in development. Here, we review PHR function across species, as well as the
myriad of signaling pathways PHR proteins regulate. These findings collectively suggest that the PHR proteins are
intracellular signaling hubs, a concept we explore in depth. Consistent with prominent developmental functions,
genetic links have begun to emerge between PHR signaling networks and neurodevelopmental disorders, such as
autism, schizophrenia and intellectual disability. Finally, we discuss the recent and important finding that PHR
proteins regulate axon degeneration, which has further heightened interest in this fascinating group of molecules.
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Background
Construction of neural circuitry relies upon axons
accomplishing several important developmental tasks.
Axons must extend and correctly navigate to a target
cell, form functional synaptic connections in the correct
location and with the correct density, and terminate out-
growth in a temporally and spatially precise fashion. A
single family of proteins called PHR proteins, named
after human Protein Associated with Myc (PAM), Dros-
ophila Highwire and C. elegans Regulator of Presynaptic
Morphology 1 (RPM-1), function in all these key steps
in the development of an axon. Here, we review genetic,
proteomic and biochemical findings that establish the
PHR proteins as functionally conserved regulators of
nervous system development from C. elegans through
mammals. We also discuss how accumulated evidence
has begun to support two major concepts regarding
PHR proteins and nervous system construction. The first
is that the PHR proteins function as intracellular
signaling hubs that regulate numerous downstream
pathways. The second is the “coordinator hypothesis”,
our postulate that the PHR proteins are likely to coord-
inate different events in axon development. Finally, we
explore the emerging and important role of PHR pro-
teins in axon degeneration.
The PHR proteins: conserved regulators of neuronal
development
The conserved PHR protein family consists of human
PAM (also called MYCBP2), mouse Phr1, zebrafish
Esrom/Phr1, Drosophila Highwire, and C. elegans RPM-
1 [1–3]. PAM was the first PHR protein discovered as
part of a phage screen for Myc binding proteins [4]. Ini-
tial functional insight emerged when independent for-
ward genetic screens revealed that Drosophila Highwire
and C. elegans RPM-1 regulate both synapse formation
and axon termination [5–7]. Subsequent studies in fish
and mice showed that PHR proteins are conserved regu-
lators of axon and synapse development [8–11]. These
functional observations are consistent with broad ex-
pression of the PHR proteins in the developing and adult
nervous system [6, 7, 9, 12–15]. Below, we explore PHR
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protein function in the developing nervous system
across species. Commentary on the mechanisms of how
PHR proteins regulate development of the nervous sys-
tem follows.
Synapse formation
Highwire has been studied extensively in the developing
larval nervous system. Loss of highwire function results
in increased numbers of abnormally small synaptic bou-
tons at the neuromuscular junction (NMJ) [5]. Defects
in synapse morphology are accompanied by increased
axon length, increased axon branching, and impaired
presynaptic transmission. Highwire function is required
exclusively in the motor neurons, as opposed to sur-
rounding muscles, for proper synapse formation and
function. In adult highwire mutants, neuronal function is
also impaired in the giant fiber system (Borgen and
Murphey, unpublished observation). Highwire functions
both cell autonomously and in the surrounding midline
glia to regulate giant fiber function.
Formation of NMJs is also abnormal in rpm-1 null
worms [6, 16]. Rather than the expanded number of
synapses observed in highwire mutants, rpm-1 mutants
have reduced synapse number. This results from large
axon segments that lack synapses despite smaller regions
of the motor axon that have increased synaptic density.
Synaptic transmission in rpm-1 mutants has not been
tested with electrophysiology, but pharmacological re-
sults suggest rpm-1 mutants could have modest defects
in GABAergic motor neuron function at the NMJ [17].
Given these pharmacological results with rpm-1 mutants
and synaptic transmission defects in highwire mutants, it
seems likely that rpm-1 mutants will have abnormal syn-
aptic transmission. Importantly, neuron-neuron synaptic
connections between the mechanosensory neurons and
interneurons are impaired in rpm-1 mutants [7]. Like
Highwire, RPM-1 functions cell autonomously in motor
neurons and mechanosensory neurons to regulate syn-
apse formation.
It is curious that loss of PHR protein function results
in different synapse morphology defects in worm and fly
motor neurons. This could be rooted in the distinct
anatomy of how fly and worm motor neurons form
synapses: worms forming synapses en passant along the
length of muscles, and flies having terminal axon
branches that innervate muscles. Alternatively, the dense
packing of presynaptic terminals in portions of the axon
in rpm-1 mutants could be thought of as regions where
expanded synapse formation is occurring. In this case, it
could be argued that a portion of the phenotype in rpm-
1 mutants is similar to what is observed in flies. How-
ever, even with this interpretation there are clearly
regions of the motor axon lacking synaptic connectivity,
which differs from the phenotype in highwire mutants.
Nonetheless, despite phenotypic differences between
rpm-1 and highwire mutants, it is clear that PHR pro-
teins regulate synapse formation in invertebrates.
Mice that lack Phr1 function die shortly after birth
due to respiratory distress from impaired innervation of
the diaphragm [9–11, 18]. Two mice with Phr1 impair-
ment have been tested for synapse defects: mice with a
small, multi-gene deletion that includes Phr1 (Phr1Df )
[9]; and gene-targeted mice that have an in-frame dele-
tion of exons 8 and 9 (Phr1Δ8,9) [10]. In both cases,
motor neurons have reduced numbers of NMJs, and
have abnormal orphan presynaptic terminals that lack
postsynaptic connections. Like invertebrates, Phr1 func-
tions cell autonomously in the motor neurons to regu-
late synapse formation [10].
These findings from worms, flies, and mammals show
that PHR proteins are conserved regulators of synapse
formation in motor neurons. However, several questions
remain unresolved. For example, do synapse formation
defects caused by loss of PHR protein function arise
from impaired synapse assembly, maturation, or stabil-
ity? Do vertebrate PHR proteins regulate synapse forma-
tion in the central nervous system?
Axon termination
Over the course of development, axons extend, reorient
growth in response to guidance cues, and form synapses.
Eventually, growth stops via a process we refer to as
axon termination. Compared to axon guidance or syn-
apse formation, we know relatively little about how axon
termination is regulated. The PHR proteins have
emerged as important, conserved regulators of axon ter-
mination. In C. elegans rpm-1 mutants, many types of
neurons have severe axon termination defects, in which
axons fail to stop at the anatomical location where ex-
tension normally halts. These neurons include: mechan-
osensory neurons (ALM and PLM) [7, 19], motor
neurons (DD and VD) [20], and pharyngeal neurons
(M1) [21]. RPM-1 functions cell autonomously in the
mechanosensory and motor neurons to regulate axon
termination. Importantly, rpm-1 mutants show defects
in both axon termination and synapse formation in sin-
gle motor neurons or mechanosensory neurons [7, 20].
Thus, RPM-1 regulates both axon termination and syn-
apse formation in individual neurons.
Relatively little is known about extracellular cues that
regulate axon termination, but progress has been made
with the PLM mechanosensory neurons of worms. Axon
termination defects caused by rpm-1 (lf ) are suppressed
by unc-6/Netrin or slt-1/Slit [22]. This suggests that
Netrin and Slit are the attractive guidance cues that fa-
cilitate abnormal PLM axon overgrowth once the axon
termination signal is impaired in rpm-1 mutants. How-
ever, the extracellular cues that trigger PLM axon
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termination would not be expected to suppress defects
in rpm-1 mutants. Rather, triggers of termination would
be expected to act in the same pathway or a parallel en-
hancer pathway to rpm-1. Consistent with this model, a
recent study showed that multiple Wnts, but primarily
LIN-44, regulate PLM axon termination [23]. In the fu-
ture, it will be important to determine if other guidance
cues function with Wnts to regulate axon termination,
and whether any of these cues function upstream of
RPM-1.
Several observations suggest that axon termination
could be impaired with loss of Highwire and Phr1 func-
tion. In larval flies, the motor neurons of highwire mu-
tants have dramatically increased axon branch length
[5]. This is often considered part of a synaptic over-
growth phenotype, but could reflect failed axon termin-
ation. The class IV dendritic arborization (C4da) larval
sensory neurons of highwire mutants have overgrown
axon terminals, which might also reflect axon termin-
ation defects [24]. It is important to note that while we
prefer to use the term axon termination, all the pheno-
types of this nature could certainly result from a failure
to restrict axon growth. Whether this reflects semantics,
or an important mechanistic distinction, will require a
much more thorough knowledge of the molecular, cellu-
lar and developmental mechanisms at play.
The sensory neurons from two different mice that lack
Phr1 function have axon termination defects. Sensory
axons in the skin fail to terminate correctly and are
heavily overextended in Phr1Df mice and Magellan
mutant mice (Phr1Mag), which have a premature stop
codon that deletes the C-terminal third of Phr1 [9, 11].
The axons of sensory neurons are bifurcated and also
have precise axon termination sites in the spinal cord
[25–27]. These termination sites in the central nervous
system are enlarged in Phr1Δ8,9 mice suggesting that
axon termination could be impaired [28].
There is also evidence of defective axon termination in
the visual system of fish and mice lacking Phr1 function.
In zebrafish esrom/Phr1 mutants, retinal axons primarily
have axon guidance defects, which we discuss in the
subsequent section. However, those retinal axons that
complete the guidance program successfully, though
small in number, have an enlarged field of axon innerv-
ation suggesting axon termination is defective [29]. Like-
wise, retinal axons targeting the superior colliculus have
enlarged termination zones in Phr1Δ8,9 mice, which sug-
gests that Phr1 regulates axon termination in a subset of
retinal ganglion cells [30].
These findings indicate that the PHR proteins are
conserved regulators of axon termination, in the per-
ipheral and central nervous system. Nonetheless, an
important question lingers. What are the underlying
cellular and developmental defects that result in failed
axon termination in animals lacking PHR protein
function?
Axon guidance
Axon extension and guidance are developmental events
that precede axon termination. A role for PHR proteins
in axon guidance was first discovered using genetic
screens in zebrafish [8, 29, 31]. In fish, retinal axons nor-
mally extend, arborize and innervate the posterior optic
tectum. esrom mutants have impaired retinal axon guid-
ance, which leads to premature anterior arborization
and failed innervation of the optic tectum [8]. Retinal
axons of esrom mutants also have reduced midline
crossing [29, 31]. Similarly, loss of Phr1 results in defect-
ive retinal axon targeting in mice [32]. Phr1Δ8,9 mice
have both abnormal number, shape, and location of ret-
inal axon projections on the dorsal-lateral geniculate nu-
cleus (dLGN). Similar to Esrom, Phr1 functions cell
autonomously in retinal axons to regulate axon targeting
to the dLGN.
The function of Phr1 in axon guidance is not limited
to the visual system. Phr1Δ8,9 mice have a plethora of
axon guidance defects in the brain indicating that Phr1
has a broad and important role in regulating construc-
tion of neural connectivity. These defects include: 1) loss
of the anterior commissure and internal capsule; 2) re-
duction in the width of the corpus callosum; 3) reduced
numbers of cortical axons; 4) loss of thalamocortical
projections; and 5) reduced sensory neuron innervation
of the olfactory bulb [10, 33]. Interestingly, defects in
axon guidance in the brain arise from Phr1 functioning
cell autonomously in neurons, as well as non-cell au-
tonomously [10]. For example, Phr1 functions cell au-
tonomously in cortical neurons to regulate axon
guidance through the corpus callosum. In contrast, de-
fects in axon guidance that result in reduced cortical
axon extension through the internal capsule are the re-
sult of non-cell autonomous Phr1 function. The guid-
ance defects in Phr1Δ8,9 mice often reflect a problem
with stalling at guidance choice point boundaries, as op-
posed to impaired axon extension. This reflects a con-
served theme for PHR proteins in axon guidance, as
axons stall at boundaries in the brains of esrom mutant
fish resulting in loss of the habenular commissure [34].
Phr1 is also an important regulator of axon guidance
in the peripheral nervous system. Extension and branch-
ing of the phrenic nerve is greatly reduced in the dia-
phragms of Phr1Df and Phr1Δ8,9 mice [9, 10]. Phr1Mag
mice were initially identified in a mutagenesis screen for
genes that regulate motor axon guidance [11]. These an-
imals have axon guidance defects at points where motor
axons exit from the spine. Further, motor axon bundles
have severely impaired guidance in the hind limb. Ab-
normal axon guidance in mice lacking Phr1 is consistent
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with the observation that cultured motor and sensory
neurons from Phr1Mag mutant mice have abnormal
growth cone morphology and dynamics [11].
While vertebrate PHR proteins are important regula-
tors of axon guidance in the central and peripheral ner-
vous system, invertebrate PHR proteins play a much
more limited role in axon guidance. In highwire mu-
tants, impaired axon guidance results in failed separation
of axon lobes in the Mushroom Body [35]. Like some
guidance events regulated by Phr1, Highwire functions
non-cell autonomously to regulate Mushroom Body
axon guidance. RPM-1 regulates axon guidance in the
AVM mechanosensory neuron and the cholinergic
motor neurons of C. elegans [22]. However, RPM-1 is
not a primary player in these guidance events, as a
Netrin (lf ) or Slit (lf ) sensitizing background is required
to reveal RPM-1 effects on guidance. Similarly, a syd-2/
liprin (lf ) sensitizing background is required to reveal a
role for RPM-1 in regulating axon extension in GABAer-
gic motor neurons [20]. These findings indicate that in-
vertebrate PHR proteins first emerge evolutionarily as
relatively minor regulators of axon guidance, but take on
greatly expanded roles in vertebrate axon guidance in
both the peripheral and central nervous system.
Axon pruning
Recent work in the developing pupal fly has shown that
Highwire regulates pruning of giant fiber axons. In adult
highwire mutants, giant fiber axons exhibit an ectopic
branch that grows past the synaptic target [36]. Careful
analysis in pupae showed that giant fiber axons normally
overshoot the desired synaptic target and are pruned
back (Borgen and Murphey, unpublished observation).
The persistence of overextended giant fiber axons in
Highwire mutants suggests that axon pruning is im-
paired. Similar to the giant fiber axons, mammalian
motor neurons undergo extensive pruning of terminal
axon branches to eliminate synapses [37, 38]. While the
presence of overextended orphan presynaptic arbors in
motor neurons lacking Phr1 could reflect axon termin-
ation defects, this defect might also result from impaired
axon pruning [9, 10]. It will be interesting to see what
other pruning events are affected by PHR proteins.
Postsynaptic and dendritic function
PHR proteins do not function solely in a presynaptic
and axonal capacity. The first example of this was the
discovery that RPM-1 regulates glutamate receptor
endocytosis at the postsynaptic terminal of interneurons
in C. elegans [39]. Likewise, Highwire regulates not only
axon termination in fly larval sensory neurons, but also
dendritic arborization [40]. As noted earlier, larval sen-
sory neurons in highwire mutants have axon termination
defects, in which axons overextend. In contrast,
dendritic arbors are reduced in length and branch num-
ber. Thus, PHR proteins can have opposing effects on
axon termination and dendrite extension in a single
neuron.
PHR protein expression and localization in neurons
The function of PHR proteins in synapse and axon devel-
opment is consistent with the subcellular localization of
these molecules in neurons. Highwire and RPM-1 are lo-
calized to the presynaptic terminal [6, 12, 13, 19], which is
consistent with PHR proteins functioning in motor neu-
rons to regulate synapse formation and function. RPM-1
is localized to a perisynaptic region of the presynaptic ter-
minal, which is adjacent to the synaptic vesicles and the
active zone. The molecular composition of the perisynap-
tic region where RPM-1 is localized remains minimally
characterized. In worms, RPM-1 is also highly concen-
trated at the mature axon tip of both motor neurons and
mechanosensory neurons [12, 19, 20]. These localization
patterns are consistent with RPM-1 regulating both axon
termination and synapse formation in single neurons.
Interestingly, the conserved PHR1 domain of RPM-1 is
necessary and sufficient for localization of RPM-1 to both
the presynaptic terminal and the axon tip [12]. While the
mechanism of how RPM-1 is localized remains unknown,
the crystal structure of the PHR1 domain indicates that
PHR1 has a relatively flat, conserved surface that is likely
to mediate protein-protein interactions [41]. The subcellu-
lar localization of RPM-1 prompts several interesting
questions. What is the temporal relationship between
RPM-1 localized at the terminated axon tip and the pre-
synaptic terminal? Does localization to one compartment
precede the other? Is RPM-1 deposited before, during or
after synapse assembly occurs?
The anatomy of fly larval motor neurons makes it dif-
ficult to distinguish Highwire at the presynaptic terminal
from Highwire that could be concentrated at the mature
axon tip. While the localization of endogenous Highwire
remains unknown, transgenic Highwire is present at pre-
synaptic boutons [13]. It is unclear if Highwire is local-
ized, or enriched at terminal boutons on the end of
motor axon branches. Addressing this could prove help-
ful in supporting or refuting the idea that increased axon
length in highwire mutants is the result of defective axon
termination, as opposed to being the result of unre-
stricted growth. Transgenic Highwire also localizes to
vesicles/puncta in motor axons and cell bodies [42].
Vertebrate PHR proteins are more broadly localized.
In cultured cortical and retinal neurons, Phr1 and Esrom
are localized to puncta throughout the axon and den-
drites, including synaptic puncta [8, 43]. Phr1 is also de-
tected in growth cones of cortical neurons. In contrast,
Phr1 is localized throughout the axon but is excluded
from growth cones in motor and sensory axons [11].
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These differing results suggest that Phr1 localization in
the growth cone could shift significantly with the devel-
opmental state of the axon, or in different types of neu-
rons. For example, motor and sensory axons might need
more rigid exclusion of Phr1 from the growth cone in
order to facilitate axon extension across the large dis-
tances they must traverse in the periphery. Nonetheless,
Phr1 localization in or around axonal growth cones is
consistent with Phr1 regulating growth cone morph-
ology and dynamics, as well as axon guidance [11, 44].
Phr1 expression and localization has not been explored
in glia, but this could be useful since Phr1 regulates
axon guidance in the brain, in part, through non-cell au-
tonomous mechanisms.
Behavior
Given the importance of PHR proteins in axon and syn-
apse development, one would expect these molecules to
impact behavior. highwire was originally named after the
mild walking defects that are present in adult highwire
mutants [5]. However, the neuronal defects that lead to
this phenotype remain unknown. Given that larval
motor neurons have abnormal synapse formation and
function, it is plausible walking defects might result from
impaired synapse development in the adult nervous sys-
tem. Alternatively, postdevelopmental functions of High-
wire in adult flies could be responsible for walking
defects. Although the motor neurons of highwire mutant
larvae have strong defects in synapse formation and
function, no defects in the locomotion of highwire larvae
have been described to our knowledge.
Quantitative behavioral analysis of adult flies showed
that highwire mutants have abnormalities in long-term
memory formation [45]. highwire mutants accumulate
long-term memories in response to aversive odors with
dramatically fewer trials than wild-type animals. This
suggests that Highwire functions as a negative regulator
of aversive memory gating. Interestingly, Highwire func-
tions post-developmentally to regulate long-term aver-
sive memory. This suggests that the axon guidance
defects in the Mushroom Body neurons of highwire mu-
tants are not severe enough to prevent formation of ol-
factory memories, and are not responsible for abnormal
gating of long-term memory.
rpm-1 mutants were initially found to have normal
locomotion and normal gentle touch sensation. This oc-
curs in spite of the fact that axon and synapse develop-
ment is impaired in the neurons that mediate these
behaviors [6, 7]. With loss of both rpm-1 and regulators
of active zone assembly, such as syd-2/liprin or syd-1,
noticeable behavioral defects emerge, in particular
strongly impaired locomotion [16, 46]. However, im-
paired locomotion is accompanied by enhanced synapse
formation defects in the inhibitory and excitatory motor
neurons [46]. Recently, more sensitive quantitative ana-
lysis uncovered mild defects in spontaneous locomotion
in rpm-1 mutants [47]. This is likely to represent the be-
havioral outcome of impaired synapse formation in the
motor neurons of rpm-1 mutants. More importantly,
rpm-1 mutants have extremely severe defects in behav-
iors that require plasticity or protracted circuit function,
such as short-term learning. Temporal rescue experi-
ments indicate that short-term learning defects in rpm-1
mutants are not a consequence of adult RPM-1 function,
but rather a consequence of developmental abnormal-
ities caused by loss of RPM-1 function. These findings
suggest that RPM-1 function in neuronal development
has relatively minor impacts on innate behavior, but dra-
matic effects on plastic behavior, such as short-term
learning.
Lethality caused by constitutive loss of Phr1 or Esrom
has limited behavioral analysis in vertebrates. The severe
axon guidance defects in the brains of Phr1Δ8,9 mice
suggest that bypassing lethality with brain-specific abla-
tion of Phr1Δ8,9 would still result in major behavioral
deficits. However, because Highwire regulates long-term
aversive memory in adult flies, it might be worthwhile to
ablate Phr1Δ8,9 in the brains of adult mice after the de-
velopmental program has been completed. Further, in-
vestigating different behavioral outcomes after ablating
Phr1 in subsets of neurons could prove informative.
PHR proteins as intracellular signaling hubs
As discussed above, PHR proteins have conserved func-
tions in synapse formation, axon guidance, and axon ter-
mination. Over the past decade, a combination of
genetic, proteomic and biochemical experiments have
greatly expanded our understanding of PHR mechanisms
of action. Below we discuss this diverse range of signal-
ing activities, which are central to our proposition that
PHR proteins function as intracellular signaling hubs.
Regulation of p38 MAP kinase, JNK MAP kinase, and TSC
signaling
The first foray into understanding how the PHR proteins
regulate synapse formation was led by the Jin and Dia-
ntonio labs [16, 48]. A predicted RING-H2 ubiquitin lig-
ase domain in the PHR proteins [5–7] and genetic
enhancer effects with the deubiquitinating enzyme Fat
Facets [49] prompted genetic suppressor screens to iden-
tify potential PHR ubiquitination targets. A MAP kinase
kinase kinase (MAP3K), called Dual Leucine zipper-
bearing Kinase 1 (DLK-1) in worms and Wallenda in
flies, was one of the first suppressors identified [16, 48]
(Fig. 1a and b). Biochemical and transgenic results indi-
cated that RPM-1 and Highwire ubiquitinate DLK-1/
Wallenda and target it for degradation by the prote-
asome [13, 16, 48]. Importantly, RPM-1 and Highwire
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function through DLK-1/Wallenda to regulate both syn-
apse formation and axon termination [19, 40]. In mam-
mals, Phr1 regulates Dlk ubiquitination and protein
stability in dorsal root ganglion (DRG) neurons [50]
(Fig. 1c). This is consistent with Phr1 restricting Dlk to
axonal growth cones of DRG neurons [11]. However,
Phr1 does not function through Dlk in all neuronal con-
texts. The dramatic defects in axon guidance in the in-
ternal capsule, the corpus callosum, and the anterior
commissure of Phr1Δ8,9 mice are not suppressed by loss
of function in Dlk, nor are Dlk levels globally upregu-
lated in the brains of Phr1Δ8,9 mice [10, 51]. Thus, a
Fig. 1 Overview of PHR protein signaling in worms, flies and vertebrates. PHR proteins function as intracellular signaling hubs that regulate
numerous signaling pathways to control neuronal development. Molecules that bind to the PHR proteins are shown adjacent to (a) RPM-1,
(b) Highwire, and (c) Phr1. For example, RPM-1 binds to ANC-1/Nesprin, GLO-4, PPM-2, RAE-1, and the FSN-1 complex. Direct protein interactions with
RPM-1 are shown in direct contact and protein interactions that could be direct or indirect are shown with open space. The location of binding on
PHR proteins is arbitrarily assigned for all proteins except RAE-1, the FSN-1/Fbxo45 complex, Myc, adenylate cyclase, Rheb, and Ran. GLO-4 binds to a
large N-terminal portion of RPM-1, but this interaction has not been more extensively mapped. To date, FBD1 has only been tested for binding to
FSN-1. Our diagram proposes that FBD1 is potentially the site where Skp anchors FSN-1/Fbxo45 on the PHR proteins. However, it is also possible FBD1
binds directly to FSN-1, and another site in the PHR proteins binds to Skp proteins. Note, several signaling pathways that function downstream of the
PHR proteins have not been explored across model systems. FSN-1/Fbxo45, DLK-1/Dlk, JNK, p38 MAPK, and RAE-1 are conserved signaling mechanisms
that mediate PHR protein function. Conserved protein domains in the PHR proteins are highlighted: RCC1-like GEF domain (RLD), PHR family specific
domains (PHR), RAE-1 binding domain (RBD), FSN-1 binding domain 1 (FBD1), Myc binding domain (MBD) and RING-H2 ubiquitin ligase
domain (RING)
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combination of genetic and biochemical experiments
across species have shown that PHR proteins function,
in part, by ubiquitination and negative regulation of
DLK-1/Wallenda.
Inhibition of DLK-1/Wallenda by the PHR proteins
impacts the function of multiple MAP kinase pathways.
RPM-1 functions in both synapse formation and axon
termination by regulating a kinase cascade composed of
DLK-1 (MAP3K), MKK-4 (MAP2K), PMK-3 (p38 MAP
kinase), MAK-2 (MAPKAP), and the transcription factor
CEBP-1 [16, 52] (Fig. 1a). Like RPM-1, several compo-
nents of the DLK-1 pathway are localized to presynaptic
terminals, and the DLK-1 pathway regulates local trans-
lation of CEBP-1 mRNA in the axon. This supports the
intriguing possibility that RPM-1 inhibition of DLK-1
could impact both local signaling activity at the pre-
synaptic terminal, and gene transcription.
rpm-1 suppressor screens also yielded mutations in uev-
3, ess-2 and supr-1 [46, 53]. UEV-3 is an E2 ubiquitin con-
jugating variant that binds to and positively regulates p38
MAPK function. It is unclear how UEV-3 regulates p38,
but UEV-3 could regulate p38 target specificity, or facili-
tate preferential activation of p38 by upstream MAP2Ks.
Alternatively, UEV-3 might regulate p38 localization, simi-
lar to the homolog UEV-1 that regulates glutamate recep-
tor trafficking [54]. ESS-2 is orthologous to mammalian
DGCR14/ES2, and regulates splicing of dlk-1 mRNA [46].
SUPR-1 has no known function, but localizes to the nu-
cleus suggesting a possible role in gene transcription.
Initial studies in Drosophila showed that Highwire in-
hibition of Wallenda/Dlk impacted the JNK ortholog, Bas-
ket, and the transcription factor c-Fos [48]. While these
initial studies suggested that different MAP kinase path-
ways might be regulated by RPM-1 and Highwire, this was
not the case as subsequent genetic analysis indicated that
RPM-1 regulates a second MAPK pathway composed of
the MAP3K MLK-1, the MAP2K MEK-1 (MKK7 ortho-
log) and the JNK isoform KGB-1 [46, 55, 56] (Fig. 1a).
Notably, the DLK-1 pathway plays a primary role in
regulating synapse and axon development in worms,
while the MLK-1 pathway plays a secondary role.
Similarly, Highwire also regulates two p38 MAPK iso-
forms [57]. RPM-1, Highwire and these downstream
MAP kinase pathways function cell autonomously in
the presynaptic neuron suggesting these are intracel-
lular signaling pathways that control axon termination
and synapse formation in invertebrate motor and sen-
sory neurons.
The axonal growth cones of motor and sensory neurons
explanted from Phr1Mag mutant mice have defects in
microtubule organization, which are suppressed by inhibi-
tors of p38 MAPK [11]. This suggests that PHR proteins
are conserved regulators of p38 MAP kinase signaling.
Mammalian Dlk also regulates MKK7 and JNK to control
neurite extension [58]. Overall, these findings argue that
the PHR proteins function as conserved inhibitors of
MAP3Ks that impact JNK and p38 MAP kinase signaling
in the developing nervous system (Fig. 1).
The ubiquitin ligase activity of PHR proteins does not
solely regulate MAP kinase cascades. The Tuberin Scler-
osis Complex (TSC), composed of TSC1/Hamartin and
TSC2/Tuberin, is also regulated by Phr1 and Highwire
(Fig. 1b and c). A yeast two-hybrid screen for TSC2
binding proteins identified a C-terminal fragment of
Phr1, and binding of Phr1 to TSC2 was confirmed from
rat brain lysate [43]. Transgenic experiments in flies pro-
vided in vivo evidence that Highwire is a conserved
negative regulator of TSC2 [43]. Consistent with this,
the brains of esrom mutant fish have increased levels of
phosphorylated TSC2 [8, 34]. Further, Phr1 regulates
ubiquitination and degradation of TSC2 in cultured
mammalian neurons, which results in inhibition of the
TSC2/TSC1 complex and activation of Rheb, mTORC1
and S6 kinase [59, 60] (Fig. 1c). Consistent with in vitro
findings, S6 kinase activity is reduced in the brains of
Phr1Mag and Phr1Δ8,9 mice, which have elevated TSC
[51]. The nature of the genetic lesions in Phr1Mag and
Phr1Δ8,9 mice suggest that Phr1 regulates mTORC1
signaling through inhibition of TSC, and unknown ubi-
quitin ligase-independent mechanisms. While Phr1 regu-
lates axon guidance in the corpus callosum, the anterior
commissure, and the internal capsule, analysis of com-
pound heterozygous Phr1Mag/Phr1Δ8,9 mice suggests that
increased TSC levels and reduced mTORC1 signaling in
these animals specifically impacts axon guidance in the
corpus callosum [51]. Thus, inhibition of TSC and activa-
tion of mTORC1 signaling is responsible for some, but
not all axon guidance defects caused by Phr1 (lf ).
Despite this important progress, findings in flies urge
caution as genetic relationships between highwire, TSC,
and mTOR are not entirely straightforward. For example,
genetically altering highwire or TSC function results in
abnormal synapse formation in motor neurons, which
suggests these players have related functions in vivo
[61]. However, while one would expect highwire (lf ) to
yield similar phenotypes to TSC overexpression, this
does not occur. NMJs are abnormally small and motor
neuron branches are longer and more extensive in high-
wire mutants than normal. In contrast, transgenic over-
expression of TSC1 and TSC2 results in reduced
numbers of NMJs and shorter axon branches. Unex-
pected genetic outcomes could reflect differences in
neuronal context that impact the relationship between
PHR proteins and TSC/Rheb/mTOR signaling, feedback
loops within the TSC/Rheb/mTOR pathway, or compen-
sation by other mechanisms that regulate activation of
mTOR. Further enhancer and suppressor analysis with
the PHR proteins and the TSC/Rheb/mTOR pathway in
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different neuronal contexts might be helpful in resolving
these issues. Nonetheless, findings in flies and mice
show that an important mechanism of PHR protein
function is inhibition of TSC.
Genetic results are consistent with the co-Smad Medea
being a potential ubiquitination target of Highwire. A
yeast two-hybrid screen with a fragment of Highwire that
is near the middle of the full-length protein sequence
identified Medea as a Highwire binding protein [62]. Syn-
apse formation defects in the NMJs of highwire mutants
are suppressed by medea (lf ) [62]. Medea regulates syn-
apse growth by functioning in a pathway with TGFβ, the
Wit BMP receptor, and the Smad transcription factor
Mad. However, we note that the relationship between
Highwire and the TGFβ/Medea pathway remains some-
what controversial as wit loss of function only partially
suppresses synaptic defects caused by highwire (lf ), and
highwire mutants do not lead to changes in phospho-Mad
levels [48]. Therefore, it remains a distinct possibility that
the TGFβ/Medea pathway might function parallel to
Highwire. Resolving these issues is likely to require further
genetic and biochemical experiments in flies and other
systems.
PHR proteins function as non-canonical SCF ubiquitin ligase
complexes
PHR ubiquitination of Dlk is mediated by a conserved bio-
chemical mechanism. Initially, RPM-1 was found to func-
tion in an SCF complex that includes the F-box protein
FSN-1, the SKR-1 Skp protein, and the CUL-1 Cullin [63]
(Fig. 1a). FSN-1 functions as the target recognition mod-
ule of the complex, and RPM-1 as the catalytic E3 ubiqui-
tin ligase. fsn-1 functions in the same pathway as rpm-1 to
regulate synapse formation and axon termination [19, 63].
Similar to RPM-1, FSN-1 is localized to the perisynaptic
region of the presynaptic terminal, and functions cell au-
tonomously in the motor neurons to regulate synapse for-
mation [63]. Defects caused by fsn-1 (lf ) are suppressed by
dlk-1 consistent with DLK-1 being a ubiquitination target
of FSN-1 [56, 64]. The receptor tyrosine kinase ALK-1/
Alk has also been implicated as a potential target of FSN-
1, but this has not been followed up or analyzed in other
systems [63].
PHR proteins in mammals and flies bind to the
orthologs of FSN-1 called Fbxo45 and DFsn, respect-
ively [65, 66]. DFsn functions in the same pathway as
highwire to regulate synapse formation, and is sup-
pressed by Wallenda/Dlk. Similar to findings in
worms, synapse formation defects are not as severe in
DFsn mutants as highwire mutants indicating DFsn is
not the sole mediator of Highwire function. Thus,
complementary results from worms and flies indicate
that PHR proteins function through FSN-1 to mediate
degradation of DLK-1.
Fbxo45−/− mice have many phenotypic similarities with
mice lacking Phr1 function [9–11, 66]. Motor neurons
have defective NMJ formation, phrenic innervation of
the diaphragm is abnormal, and sensory neurons have
axon termination defects in the periphery. In the brain,
axon guidance is impaired. Finally, Fbxo45−/− mice die
shortly after birth due to respiratory distress. Notably,
not all axon guidance defects in the brains of Phr1Δ8,9
mice are present in Fbxo45−/− animals, which suggests
Phr1 functions through mechanisms that are independ-
ent of Fbxo45. Consistent with common phenotypic out-
comes, Fbxo45 binds to Phr1, is expressed in the
nervous system, and localizes to the synapse similar to
Phr1 [66, 67]. Thus, Fbxo45 is a conserved mechanism
of PHR protein function. While PHR proteins function
through orthologs of Fbxo45 to regulate Dlk in worms
and flies, it remains unclear if Fbxo45 targets Dlk in
mammals. Fbxo45 is unlikely to be the mechanism by
which Phr1 ubiquitinates TSC2 for two reasons. First,
Phr1Δ8,9 and Phr1Mag mice, but not Fbxo45−/− mice,
have increased amounts of TSC2 [51]. Second, overex-
pression of Phr1 in 293 cells, but not overexpression of
Fbxo45, increases mTOR activity.
The composition of SCF complexes formed by PHR
proteins differs across species. As noted earlier, C. ele-
gans RPM-1 is in a complex with FSN-1, SKR-1 and
CUL-1 [63]. In contrast, proteomic and biochemical
analysis indicate that Highwire and Phr1 form con-
served, non-canonical SCF complexes containing SkpA
and DFsn in flies, and Skp1 and Fbxo45 in mammals
[66, 68]. Because Cullins are normally adaptors that bind
to all components of a canonical SCF complex [69], it is
highly unlikely proteomic screens with Highwire would
identify DFsn and SkpA, but fail to detect a Cullin if one
existed in this complex. Further, mutation of a single
residue in the F-box domain of Fbxo45 explains the ab-
sence of a Cullin in the non-canonical Phr1/Skp1/
Fbxo45 complex [66]. These findings indicate that PHR
proteins generally form non-canonical ubiquitin ligase
complexes that use the F-box protein Fbxo45 as a con-
served target recognition module.
The enormous size of the PHR proteins (which are lar-
ger than 400 kDa) limited structure-function analysis for
sometime. Initial progress came with the discovery that
Fbxo45 binds to the same large fragment of Phr1 that
binds Myc [66]. Subsequent biochemistry mapped binding
of FSN-1 to a smaller, conserved domain in RPM-1, re-
ferred to as FSN-1 binding domain 1 (FBD1) [70]. FBD1
corresponds entirely to the conserved region of Phr1 that
binds to Fbxo45, and all conserved motifs in FBD1 are re-
quired for binding to FSN-1. Therefore, FBD1 is likely to
be a conserved structural mechanism that mediates PHR
binding to F-box proteins. Transgenic overexpression of
FBD1 results in genetic interactions and axon termination
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defects similar to fsn-1 (lf ). As a result, recombinantly
expressed FBD1 is referred to as the RPM-1/FSN-1 com-
plex inhibitory peptide (RIP). RIP is the first inhibitor of
PHR protein function with a known biochemical mechan-
ism of action and in vivo efficacy. Future structure-
function analysis will be necessary to test two questions:
1) Does FBD1 function as a conserved site of interaction
between Phr1 and Fbxo45? 2) Does FBD1 mediate direct
binding to Fbxo45, or mediate direct binding to Skp1 and
recruitment of Fbxo45?
Beyond ubiquitin ligase activity: the PHR proteins as
signaling hubs
Central to the idea that PHR proteins functions as intra-
cellular signaling hubs is evidence that PHR proteins are
not solely ubiquitin ligases. Proteomic screens with C.
elegans RPM-1 and Drosophila Highwire have revealed
several proteins that bind to PHR proteins, mediate PHR
signaling, and are unlikely to be targets of PHR ubiquitin
ligase activity (Fig. 1a and b).
The first proteomic screen with a PHR protein was
performed with C. elegans RPM-1 [19]. This was one of
the earliest proteomic screens performed in C. elegans
using a protein expressed exclusively in the nervous sys-
tem, and identified numerous functional RPM-1 binding
proteins. The first of these was Gut Granule Loss 4
(GLO-4), a putative Rab GEF referred to as Claret in
flies [19, 71]. Genetic enhancer analysis revealed that
glo-4 and fsn-1 function in parallel pathways with each
mediating a portion of rpm-1 function in synapse forma-
tion and axon termination. RPM-1 positively regulates
GLO-4 as part of a pathway that includes the Rab
GTPase GLO-1 and APM-3/AP3. GLO-4 colocalizes
with RPM-1 at the mature axon tip and in presynaptic
terminals at the perisynaptic zone, but RPM-1 is not re-
quired for GLO-4 localization. GLO-4 specifically regu-
lates the RAB-7 late endosomal compartment at
presynaptic terminals. Thus, RPM-1 is likely to function
locally at the axon tip and the presynaptic terminal via
the GLO-4/GLO-1/APM-3 pathway to regulate late en-
dosome trafficking or lysosome biogenesis. Unlike high-
wire mutants, claret mutants do not have axon
termination defects in larval C4da sensory neurons, or
giant fiber pruning defects [40] (R. Murphey, personal
communication). However, because fsn-1 (lf ) was needed
as a sensitizing genetic background to fully reveal the
role of glo-4 in axon and synapse development in
worms, results from flies do not conclusively rule out
the possibility that GLO-4 is a conserved mechanism of
PHR protein function. Similar lines of thinking apply to
GLO-1, which has conserved orthologs in flies (Lightoid)
and in mammals (Rab32, Rab38, and Rab7L1).
This proteomic screen for RPM-1 binding proteins iden-
tified several other proteins that mediate a portion of
RPM-1 function including: the microtubule binding pro-
tein RNA Export 1 (RAE-1) [72], the PPM/PP2C family
phosphatase PPM-2 [64], and the Nesprin ANC-1 [23]
(Fig. 1a). Importantly, Rae1 was simultaneously isolated in
a proteomic screen for Highwire binding proteins [73]. In
yeast, RAE-1 regulates nuclear export of RNA via binding
to the nucleoporin Nup98 [74, 75]. In metazoans, RAE-1
regulates microtubule stability and spindle assembly in
mitotic cells, and has a more limited or no role in RNA
export [76–80]. A single domain in RPM-1 and Phr1 is
sufficient to mediate binding to RAE-1, and this inter-
action requires a small conserved motif in the PHR pro-
teins [72]. Mutation of this motif reduces binding of RAE-
1 to RPM-1 in vivo in neurons. Genetic findings in flies
and worms show that rae-1 functions in the same pathway
as highwire and rpm-1 to regulate synapse formation and
axon termination [72, 73]. This is consistent with RAE-1
colocalizing with RPM-1 at the presynaptic terminal. Des-
pite these similar genetic and biochemical findings, differ-
ences exist in the relationship between PHR proteins and
RAE-1. In the mechanosensory neurons of worms, RAE-1
regulates axon termination by functioning downstream of
RPM-1 [72]. In contrast, Rae1 protects Drosophila High-
wire from degradation by autophagy suggesting Rae1 can
function upstream of Highwire [73]. These differences
might be explained by autophagy mediating feedback
between Rae1 and the PHR proteins. Alternatively,
the relationship between PHR proteins and Rae1
might differ with neuronal context. Nonetheless, a
combination of biochemical and genetic results across
species indicates that RAE-1 is a conserved mediator
of PHR protein function.
Identification of the PPM-2 phosphatase as an RPM-1
binding protein led to the first evidence that PHR pro-
teins employ multiple, independent mechanisms to regu-
late a single protein target, the DLK-1 MAP3K [64]
(Fig. 2). RPM-1 inhibits DLK-1 activation via PPM-2,
and regulates DLK-1 stability via FSN-1. This raises in-
teresting implications for the spatial and temporal con-
trol of DLK-1 during development. For example, RPM-1
might function through PPM-2 to inhibit activation of
DLK-1 locally at presynaptic terminals or terminating
axon tips, and inhibit DLK-1 activity more globally over
longer developmental time frames by regulating DLK-1
ubiquitination and degradation.
In worms, there are two isoforms of DLK-1, a full
length isoform called DLK-1L and a short, inhibitory
isoform called DLK-1S [81] (Fig. 2). Dephosphorylation
of two serine residues in a C-terminal hexapeptide motif
in DLK-1L stabilizes binding to DLK-1S resulting in for-
mation of inactive DLK-1L/DLK-1S heterodimer. It is
unclear if dephosphorylation of one or both of the serine
residues in the DLK-1L hexapeptide causes heterodi-
merization. Calcium signaling also regulates DLK-1S
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inhibition of DLK-1L. PPM-2 inhibits DLK-1L by specif-
ically dephosphorylating a single serine residue, S874, in
the hexapeptide [64]. Thus, both DLK-1S and PPM-2 act
on the same motif to inhibit DLK-1L. However, it re-
mains unknown if PPM-2 directly inactivates DLK-1L
independent of DLK-1S, or if PPM-2 dephosphorylation
of DLK-1L is required for binding of DLK-1S. Despite
the importance of the hexapeptide for regulation of
DLK-1 in worms, this motif is not conserved in Dros-
ophila or mammalian Dlk/MAP3K12 [81, 82]. However,
the hexapeptide is conserved in Lzk/MAP3K13, which is
highly homologous to Dlk. MAP3K13 can complement
DLK-1 function in worm neurons [81], and MAP3K13
functions in neurite outgrowth mediated by the Nogo
receptor [83]. These functional observations and evi-
dence that MAP3K13 binds to Dlk [84] should prompt
further exploration of MAP3K13 function in the devel-
oping nervous system. Conservation of PPM-2 in flies
and the protochordate Ciona intestinalis, as well as con-
servation of the hexapeptide site where PPM-2 acts in
MAP3K13 suggest that PPM-2 is likely to be a con-
served mechanism of regulating MAP3K signaling.
The DLK-1 pathway is inhibited by a second phos-
phatase in the PPM/PP2C family, PPM-1, which is
orthologous to mammalian PPM1α/PP2Cα and PPM1β/
PP2Cβ [85] (Fig. 2). While PPM-2 specifically inhibits
DLK-1 [56, 64], PPM-1 is a broad negative regulator of
both the DLK-1 and MLK-1 pathways [56, 85]. Genetic
results have hinted at the possibility that PPM-1 acts on
the p38 MAPK PMK-3 in the DLK-1 pathway, but bio-
chemistry from cultured cells leaves open the possibility
that PPM-1 could inhibit MAP2Ks or MAPKs in the
DLK-1 and MLK-1 pathways. Unlike PPM-2, there is no
evidence indicating that PPM-1 binds to RPM-1. Thus, a
network of negative regulatory mechanisms restricts
DLK-1 in the neurons of C. elegans.
A genetic screen for NMJ morphology in fly motor
neurons identified the actin and microtubule binding
protein Spectraplakin as a negative regulator of Dlk sig-
naling [82]. The molecular basis of how Spectraplakin
inhibits Dlk signaling remains unclear. However, TCP1 a
chaperone complex that mediates folding of actin and
tubulin also regulates Dlk signaling suggesting that acti-
vation of Dlk is affected by cytoskeletal polymerization
and/or stability.
The last RPM-1 binding protein identified via proteo-
mics was the Nesprin ANC-1 [23] (Fig. 1a). C. elegans
has a single gigantic isoform of ANC-1 (greater than
800 kDa) that is orthologous to MSP-300/Nesprin in
flies, and Nesprin-1 and Nesprin-2 in mammals [86].
Loss of function in anc-1 does not result in dramatic de-
fects in synapse formation or axon termination, but en-
hancer effects were observed with an fsn-1 (lf )
background [23]. Similar to all other RPM-1 binding
proteins identified by proteomics, loss of function in
anc-1 does not suppress axon termination or synapse
formation defects caused by rpm-1 (lf ). These biochem-
ical and genetic results are consistent with ANC-1 being
positively regulated by RPM-1, as opposed to being ubi-
quitinated and degraded by RPM-1. RPM-1 and ANC-1
function in a pathway with the β-catenin BAR-1 and the
transcription factor TCF/POP-1. Thus, the RPM-1/
ANC-1/β-catenin/POP-1 pathway is likely to regulate
axon and synapse development by impacting gene
Fig. 2 A negative regulatory network inhibits the DLK-1 pathway in C. elegans. Shown are the negative regulatory mechanisms that function as a
network to restrain the activity of the DLK-1 MAP kinase pathway in the motor neurons and mechanosensory neurons of C. elegans. RPM-1 binds
to PPM-2, and PPM-2 directly dephosphorylates and inhibits DLK-1 L. DLK-1S heterodimerizes with and inhibits DLK-1 L. RPM-1 and FSN-1 function
as a complex to ubiquitinate DLK-1 L and target it for degradation. Finally, PPM-1 inhibits the DLK-1 pathway, most likely by dephosphorylating
and inhibiting PMK-3 or MKK-4
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transcription. This is consistent with ANC-1 functioning
at the nuclear envelope to regulate β-catenin, most likely
by antagonizing EMR-1/Emerin, a known regulator of β-
catenin export. Further, a combination of canonical Wnt
signaling and non-canonical RPM-1/ANC-1 complex
function is likely to converge on β-catenin and regulate
axon termination.
Taken as a whole, several important themes emerge
from these in vivo proteomic and genetic studies on
RPM-1. 1) All RPM-1 binding proteins identified to date
mediate a portion of RPM-1 function. Therefore, simul-
taneous loss of function in multiple pathways that func-
tion downstream of RPM-1 is required to cause the
severe axon termination and synapse formation defects
observed in rpm-1 null animals. 2) RPM-1 both posi-
tively and negatively regulates downstream signaling
pathways. 3) All RPM-1 binding proteins and down-
stream pathways that are known regulate both axon ter-
mination and synapse formation, rather than pathways
having preferential effects on a particular developmental
outcome. 4) All RPM-1 binding proteins and down-
stream pathways function cell autonomously to regulate
axon termination and synapse formation. 5) RPM-1 is
likely to affect both local signaling in the axon or pre-
synaptic terminal, as well as impact gene transcription.
6) Finally, RPM-1 employs multiple, independent mech-
anisms to regulate a single target molecule, DLK-1.
These findings suggest that RPM-1 is an intracellular
signaling hub that uses an array of sophisticated mecha-
nisms to control axon and synapse development.
Whether this definitively emerges as an overarching
theme for how all PHR proteins function will require
further investigation in fly and vertebrate model systems.
Importantly, identification of upstream signals that regu-
late PHR protein function in vivo will be essential to
more definitively establish the PHR proteins as intracel-
lular signaling hubs.
The conserved RCC1-like domain of PHR proteins has several
biochemical activities
In vitro approaches have identified several Phr1 biochem-
ical activities that could affect intracellular signaling and
gene transcription. These findings further support our
proposition that the PHR proteins function as intracellular
signaling hubs (Fig. 1c, right panel). However, it remains
largely unknown if PHR proteins function through these
biochemical activities to regulate neuronal development
in vivo.
The Bishop lab first identified Phr1 (also referred to as
Pam) in a screen for Myc binding proteins [4]. The Myc
binding domain (MBD) of Phr1 encompasses an N-
terminal region that is conserved in RPM-1 and High-
wire, and a C-terminal non-conserved region [70]. The
conserved N-terminal region corresponds with FBD1,
the domain in RPM-1 that mediates binding to FSN-1.
Because all conserved motifs in FBD1 are required for
binding to FSN-1 [70] and proteomic screens for pro-
teins that bind to RPM-1 and Highwire have not identi-
fied Myc [19, 23, 64, 73], it is likely that Myc binds to
the portion of the MBD that is not conserved in RPM-1
or Highwire.
The RCC1-like domain (RLD) of Phr1 binds to several
molecules. Yeast two-hybrid screens identified different
regions of the RLD that bind to type V adenylate cyclase
[87], and the potassium-chloride co-transporter KCC2
[88]. The RLD inhibits type II and V adenylate cyclases
in vitro, which is consistent with anti-sense oligonucleo-
tides against Phr1 increasing adenylate cyclase activity
and cAMP levels in cultured cells and neurons of the
spinal cord [87, 89, 90]. Coimmunprecipitation verified
binding of KCC2 to the RLD, and the RLD stimulates
transporter activity in cultured cells [88]. Interestingly,
the RLD acts as a Guanine Nucleotide Exchange Factor
(GEF) for Rheb and Ran in vitro, which is consistent
with homology between the RLD of Phr1 and the Ran
GEF RCC1 [60, 91]. In cultured DRG neurons, loss of
Phr1 results in increased Ran localization in the nucleus,
which is consistent with Phr1 functioning as a Ran GEF
[91]. SUMOylated RanGAP1, which inactivates Ran, also
binds to Phr1 and inhibits Phr1 ubiquitin ligase activity.
These biochemical activities of the RLD are intriguing,
and future experiments testing how Phr1 regulation of
adenylate cyclase, KCC2, or Rheb impacts neuronal de-
velopment and/or function in vivo is eagerly awaited.
PHR protein signaling impacts the microtubule cytoskeleton
Genetic, biochemical and pharmacological approaches
have highlighted important links between PHR protein
function and the microtubule cytoskeleton. For example,
in explants of cultured sensory neurons from Phr1Mag
mice, axonal growth cones have abnormal morphology
and disorganized microtubules, which is consistent with
Phr1 binding to polymerized microtubules [11]. Applica-
tion of taxol (a microtubule stabilizer) rescues these de-
fects suggesting that Phr1 stabilizes microtubules or
facilitates microtubule polymerization. Cultured cortical
explants from esrom mutant fish also have abnormal
growth cone morphology that results from microtubule
defects [44]. However, application of nocodazole (a
microtubule depolymerizing agent) rescues this pheno-
type suggesting that Phr1 inhibits microtubule assembly
or positively regulates disassembly. These opposing
pharmacological outcomes could reflect differences in
the type of neurons analyzed, developmental timing, or
the use of in vitro cell culture systems.
Two other observations link PHR protein function to
the microtubule cytoskeleton. The first is that Dlk regu-
lates microtubule dynamics in many types of neurons
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and cultured cells [57, 82, 92–95]. The second is that in-
vertebrate PHR proteins bind to and function through
RAE-1, a microtubule binding protein [72, 73, 96]. Con-
ceivably, RAE-1 might mediate binding of PHR proteins
to microtubules, or act as a mechanism by which PHR
proteins impact microtubule dynamics. This body of
work prompts two important questions. 1) How do PHR
proteins integrate with known regulators of microtubule
assembly and disassembly? 2) How do PHR proteins im-
pact microtubule stability and growth cone development
in vivo?
At present, very little is known about whether PHR
proteins regulate the actin or intermediate filament cyto-
skeleton, but two observations hint at this possibility.
First, Phr1 binds to polymerized F-actin in vitro, and F-
actin inhibits Phr1 ubiquitin ligase activity [97]. Second,
Phr1 binds to Gigaxonin, an intermediate filament bind-
ing protein [98]. This is a potentially interesting observa-
tion, not only because of the implication that PHR
proteins might regulate intermediate filaments, but also
because mutations in Gigaxonin cause giant axonal
neuropathy.
The coordinator hypothesis
Synapse formation, axon guidance, and termination of
axon outgrowth are often analyzed individually, but these
developmental events are temporally and spatially coordi-
nated. For example, there is a tight temporal link between
axon extension and synaptogenesis in developing fish and
frog RGCs, cultured mammalian hippocampal neurons,
and Drosophila motor neurons [99–106]. Impaired synap-
tic activity in worms, flies and fish leads to abnormal axon
outgrowth and branching [100, 107–109]. Morphogens,
axon guidance cues, and cell adhesion molecules function
in both axon outgrowth and synapse formation [110]. This
could result from repurposing extracellular cues at differ-
ent times and with differing neuronal context during
development, but it might also reflect the role of extracel-
lular signals in coordinating axon outgrowth and termin-
ation with synapse formation. Examples of guidance cues
regulating both axon guidance and synapse formation in a
single type of neuron are exemplified by the role of UNC-
6/Netrin in the RIA and AIY neurons [111], and UNC-6
and Wnt effects on the DA9 motor neuron in worms
[112–114]. In adult flies, Netrin regulates short-range
axon guidance, as well as electrical synapse formation and
function in the giant fiber [115]. These findings suggest
that coordination of synapse formation with axon out-
growth and termination is likely to be a conserved feature
of nervous system development. Nonetheless, the intracel-
lular signaling mechanisms that regulate coordination re-
main poorly understood.
Two groups have suggested that PHR proteins regulate
transitions between axon and synapse development [2, 22].
We would take this a step further by suggesting that the
PHR proteins are intracellular signaling hubs that could
function to coordinate different events in axon develop-
ment [64]. This is a postulate we refer to as the “coordin-
ator hypothesis”. The coordinator hypothesis rests on
several observations from different systems. 1) As discussed
earlier, the PHR proteins are likely to function as intracellu-
lar signaling hubs, which both positively and negatively
regulate multiple downstream pathways. PHR hub function
is of central importance to the coordinator hypothesis, as
sophisticated signal regulation is likely to be characteristic
of a coordinator. An excellent example of sophisticated sig-
nal regulation is RPM-1 utilization of both phosphatase
and ubiquitin ligase mechanisms to regulate a single mol-
ecule, DLK-1 [64]. This allows RPM-1 to potentially regu-
late local, fast-acting DLK-1 activity as well as long-term
DLK-1 protein stability and turnover. 2) PHR proteins are
functionally promiscuous with conserved roles in a range
of events in axon development including: synapse forma-
tion, axon guidance, and axon termination. 3) The PHR
proteins regulate multiple developmental events in the
same, single neuron. For example, RPM-1 and Highwire
function cell autonomously in the mechanosensory neurons
and the motor neurons to regulate both synapse formation
and axon termination in single cells [5–7, 20]. 4) Finally,
there is evidence that PHR proteins are localized to mul-
tiple subcellular compartments within a single neuron. For
example, RPM-1 is localized at the mature, terminated
axon tip and the presynaptic terminal in mechanosensory
and motor neurons [6, 12, 20]. Low levels of RPM-1 are
also present in neuronal cell bodies, and RPM-1 functions
through ANC-1, which acts at the nuclear envelope [23].
Thus, RPM-1 potentially affects signaling in three subcellu-
lar compartments.
While the coordinator hypothesis is an intriguing and
potentially unifying concept of PHR protein function,
important questions remain regarding this postulate. For
one, are PHR proteins regulated by upstream signals, in
particular, extracellular signals? Two observations have
hinted at this possibility. In flies and worms, PHR pro-
teins affect signaling pathways that are regulated by
extracellular cues, such as BMP and Wnt [23, 62]. Thus,
PHR protein activity does integrate with signals coming
from outside the cell. Second, serum stimulation of cul-
tured DRG neurons increases nuclear localization of
Phr1 [91]. The elusive nature of potential upstream cues,
despite extensive genetic screens that identified both
Highwire and RPM-1, suggests that multiple upstream
signals are likely to regulate the PHR proteins. Another
important question is whether or not PHR proteins, or
molecules downstream of PHR proteins, traffic between
different subcellular compartments. Finally, and most
importantly, can we find direct in vivo evidence that loss
of PHR protein function impairs coupling of synapse
Grill et al. Neural Development  (2016) 11:8 Page 12 of 18
formation and axon termination. Addressing these ques-
tions will be essential in refuting or further supporting
the coordinator hypothesis.
Postdevelopmental functions of PHR proteins
PHR proteins have important functions in development
of the nervous system, but PHR expression persists into
adulthood. For example, endogenous and transgenic
RPM-1 is detected at both the mature axon tip and the
presynaptic terminals of motor and mechanosensory
neurons in adults [6, 7, 20]. Transgenic Highwire is local-
ized to presynaptic terminals at NMJs after completion of
larval development [13]. Likewise, Phr1 mRNA and pro-
tein are expressed in the adult rodent brain [14, 15, 116].
Consistent with expression into adulthood, PHR proteins
have important postdevelopmental functions. We already
touched on Highwire regulation of long-term aversive
memory in adult flies. Here, we focus on the prominent
role of PHR proteins in axon degeneration.
Axon degeneration after injury
PHR proteins are conserved regulators of axon degener-
ation following traumatic injury. The first evidence for
this came from genetic studies in flies, which showed
that highwire (lf ) dramatically blocks degeneration of
neuromuscular junctions caused by α-spectrin knock-
down [117, 118]. highwire mutants also show striking re-
sistance to axon degeneration induced by trauma [119].
Crushing the body of a larval fly results in motor axon
severing, and the severed axon segment undergoes a
form of degeneration referred to as Wallerian degener-
ation [120]. Wallerian degeneration is vigorously blocked
in highwire mutants, and functional synaptic connec-
tions are maintained in severed axons [119].
In vivo mouse models of Wallerian degeneration in
the peripheral and central nervous system involve axot-
omy of the sciatic or optic nerve, respectively. In both
cases, the distal axon fragment degenerates extensively
within 3–5 days. In contrast, axon degeneration is dra-
matically halted in Phr1Δ8,9 mice [121]. Like flies, sev-
ered axons not only persist robustly for 5–10 days after
axotomy, but synapses also remain intact for several
days. Axon degeneration induced by neurotoxicity is also
reduced in Phr1Δ8,9 DRG neurons.
Highwire and Phr1 regulate axon degeneration by func-
tioning cell autonomously in damaged neurons. In flies,
Highwire regulates axon degeneration primarily by ubiqui-
tinating and regulating levels of NMNAT, and secondarily
by regulating levels of Dlk/Wallenda [119] (Fig. 3a).
Mammals have multiple isoforms of NMNAT, and Phr1
functions specifically through NMNAT2 to regulate axon
degeneration [121] (Fig. 3b). In mice, Dlk (lf ) gives similar,
but much more minor, effects compared to Phr1 (lf )
[122]. This suggests that Phr1 is unlikely to regulate axon
degeneration via Dlk. If this were the case, we would ex-
pect Phr1 (lf ) to have similar phenotypes to Dlk overex-
pression not Dlk (lf ). While it is unclear if RPM-1
regulates axon degeneration in worms, excess NMNAT
does reduce axon degeneration [123]. These findings indi-
cate that PHR proteins are conserved, central players in
an actively regulated axon degeneration program.
The molecular mechanism of how PHR proteins ubi-
quitinate NMNAT remains unclear. However, the F-box
protein Fbxo45 binds NMNAT in HEK 293 cells sug-
gesting that Fbxo45 could mediate Phr1 ubiquitination
of NMNAT [121]. If this proves to be the case, molecules
that inhibit the Phr1/Fbox45 complex could be potent in-
hibitors of axon degeneration. Interestingly, increased
NMNAT function is protective in several models of neu-
rodegenerative disease including: glaucoma, axonopathies,
Parkinson’s disease, and Tauopathy [120]. Thus, inhibitors
of the Phr1/Fbxo45 complex could prove potentially use-
ful in slowing the progression of several neurodegenera-
tive diseases. Recent work in worms identified RIP as an
in vivo inhibitor of the RPM-1/FSN-1 complex [70]. This
could represent an important first step towards developing
inhibitors of the Phr1/Fbxo45 complex.
Axon regeneration after injury
PHR proteins play a modest role in axon regeneration.
In worms, laser axotomy of individual neurons is used
to assess axon regeneration [124]. Loss of function in
rpm-1 or fsn-1 modestly increases axon regeneration in
motor neurons [55, 125]. Similarly, highwire (lf ) acceler-
ates axon regeneration in fly motor neurons [42]. Both
RPM-1 and Highwire function through DLK-1/Wallenda
to regulate regeneration [52, 125]. Young worms regen-
erate with much greater capacity than older worms, and
the improvements in axon regeneration that come with
increased DLK-1 function are noticeably more pro-
nounced in older animals [125]. Therefore, loss of func-
tion in rpm-1 or other molecules that lead to increased
DLK-1 activity might give more prominent improve-
ments in regeneration in older animals where regener-
ation is more limited. To our knowledge, it is unknown
if loss of Phr1 results in improved axon regeneration in
mammals, but Dlk is required for axon regeneration in
mammals similar to invertebrates [126, 127]. These con-
served functional outcomes in different model systems
suggest that PHR proteins are likely to influence an im-
portant molecular choice point that regulates the bal-
ance between axon regeneration and axon degeneration.
Emerging genetic links between the PHR protein
signaling network and neurodevelopmental disorders
To our knowledge, direct genetic links between human
MYCBP2/PAM and neurodevelopmental disorders have
not been found. This includes a study that examined the
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MYCBP2 locus in 300 autism patients [128]. However,
there are numerous genetic links between signaling
pathways that are regulated by PHR proteins and neuro-
developmental disorders.
The most prominent of these links is Phr1 regulation
of TSC [43, 51, 59]. Mutations in TSC1 or TSC2 cause
tuberous sclerosis, which results in non-malignant tu-
mors in the brain, autistic behavior, intellectual disabil-
ity, and seizures [129, 130]. Many of these symptoms
potentially result from brain tumors, but might also
stem from increased mTOR signaling which leads to de-
fects in synapse formation, function, or plasticity. Inter-
estingly, one disease-associated mutation in TSC2 causes
increased ubiquitination by Phr1 [59]. As a result,
enhanced degradation of TSC2 by Phr1 might directly
impact a subset of patients with tuberous sclerosis.
As discussed earlier, Fbxo45 functions in a ubiquitin
ligase complex with Phr1. Fbxo45 is one of several genes
deleted in 3q29 microdeletion syndrome, which results
in autism, intellectual disability, and schizophrenia
[131–135]. Fbxo45 is duplicated in patients with 3q29
microduplication syndrome, which results in intellectual
disability and seizures [136, 137]. 3q29 deletion and
duplication regions contain several genes of neuronal
relevance, but the role of Fbxo45 in neuronal develop-
ment and synaptic function suggests it could be a rele-
vant player in these syndromes. A mutation in Fbxo45 is
also associated with schizophrenia [138]. Interestingly,
microdeletions [139–141] and microduplications [142,
143] that include Dlk/MAP3K12, a likely Fbxo45 ubiqui-
tination target, also result in intellectual disability and
autism. Splicing of dlk-1 in worms is regulated by
DGCR14/ES2 [46]. DGCR14 is present in chromosomal
deletions implicated in DiGeorge syndrome, which is
characterized by autism and schizophrenia [144–148].
While these findings might be a coincidence, they could
also reflect the conserved functional relationship be-
tween Fbxo45, Dlk, and Phr1.
Fig. 3 Overview of PHR protein signaling that regulates injury-induced axon degeneration in flies and mice. Shown are signaling pathways that
mediate PHR protein function in axon degeneration. a Drosophila Highwire functions through both Dlk/Wallenda and NMNAT to regulate axon
degeneration. b Phr1 functions through NMNAT2 to regulate axon degeneration. The MAP2K and MAPK that mediate Dlk/Wallenda function in
axon degeneration remain unknown, but are likely to be either JNK or p38 MAPK based upon findings in the context of neuronal development
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The discovery that RPM-1 functions, in part, by bind-
ing to the Nesprin ANC-1 opens up another genetic link
between PHR signaling and neurodevelopmental dis-
orders. C. elegans ANC-1 is most similar to mammalian
Nesprin-1 (also called Syne1). Mutations in Nesprin-1
cause cerebellar ataxia [149–153], and are associated
with autism [154, 155]. Further, Nesprin-1 SNPs are
associated with bipolar disorder [156–160] and schizo-
phrenia [161, 162]. Collectively, these findings highlight
potentially important genetic links between PHR signal-
ing and neurodevelopmental disorders.
Conclusions
Research over the past decade has greatly expanded our un-
derstanding of the PHR proteins on numerous fronts. 1)
Mounting evidence indicates that PHR proteins both posi-
tively and negatively regulate multiple downstream signal-
ing pathways, at times through sophisticated mechanisms.
Thus, rather than solely functioning as ubiquitin ligases, the
PHR proteins are most likely intracellular signaling hubs. 2)
Collective results, particularly from worms, have begun to
coalesce around the concept of the PHR proteins as signal-
ing hubs that coordinate different events in neuronal devel-
opment, a postulate we refer to as the coordinator
hypothesis. 3) Consistent with an important and broad role
in neuronal development, a striking number of genetic links
between PHR signaling networks and neurodevelopmental
disorders have emerged. 4) Finally, PHR proteins are im-
portant regulators of axon degeneration, which has poten-
tially important implications regarding neurodegenerative
disease. While this highlights exciting progress, much still
remains to be learned about these physically enormous and
molecularly rich signaling molecules.
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